Table 2.
Follow up |
||||||
---|---|---|---|---|---|---|
Persistent asthma, OR (95%CI) |
COPD, OR (95%CI) |
|||||
Determinants, Baseline |
All (n = 164) | Early-onset asthma (n = 74)a | Late-onset asthma (n = 81)a | All (n = 35) | Early-onset asthma (n = 16)b | Late-onset asthma (n = 15)b |
Sex, female | 0.70 (0.35–1.40) | 0.69 (0.17–2.83) | 0.70 (0.26–1.84) | 1.43 (0.61–3.38) | 20.40(1.57–265.69) | 0.71 (0.15–3.33) |
FEV₁ below pred | 2.12 (0.98–4.61) | 7.12(1.61–31.50) | 1.53 (0.53–4.40) | 3.05 (0.67–13.91) | 2.91 (0.23–37.35) | NA |
Bronchial hyperresponsiveness | 1.01 (0.51–2.00) | 2.18 (0.36–13.21) | 1.13 (0.43–2.97) | 0.79 (0.35–1.81) | 0.06(0.01–0.56) | 3.04 (0.68–13.70) |
ACOS | 2.60 (0.89–7.62) | 2.81 (0.23–34.00) | 1.27 (0.29–5.63) | 6.98(2.84–17.14) | 204.96(9.20–4566.65) | 15.53(3.22–74.76) |
Asthma Score per step increase. | 1.21 (0.94–1.56) | 2.06(1.15–3.68) | 1.12 (0.80–1.56) | 1.03 (0.78–1.37) | 1.39 (0.81–2.39) | 0.84 (0.52–1.34) |
Medication, 12 mth | ||||||
SABA only | 3.39(1.47–7.82) | 4.52 (0.81–25.22) | 2.26 (0.69–7.42) | 0.90 (0.27–2.99) | 5.06 (0.60–42.67) | 0.25 (0.02–2.84) |
ICS and/or LABA | 8.95(3.87–20.69) | 9.87(1.95–49.98) | 6.84(2.09–22.37) | 1.22 (0.41–3.59) | 0.38 (0.05–3.19) | 1.29 (0.19–8.67) |
Current smoking | 0.45(0.21–0.94) | 1.01 (0.20–5.15) | 0.98 (0.35–2.72) | 1.86 (0.74–4.70) | 4.54 (0.67–30.53) | 2.25 (0.51–10.00) |
High-risk occupation (asthma) c | 2.48 (0.45–13.72) | 1.18 (0.04–33.77) | 1.97 (0.26–14.90) | 0.35 (0.03–3.59) | NA | 0.08 (0.00–2.33) |
High-risk occupation (COPD)d | 0.53 (0.10–2.87) | 1.25 (0.04–36.31) | 0.57 (0.08–4.15) | 1.93 (0.20–18.83) | NA | 7.78 (0.31–197.17) |
Bold values denote significant associations (p < 0.05).
an (total) = 155 due to missing data on age at first asthma attack.
bn (total) = 31 due to missing data on age at first asthma attack.
cn = 236; 3 participants had missing in variable ‘high-risk occupation (asthma)’.
dn = 236; 3 participants had missing in variable ‘high-risk occupation (COPD)’.
NA: Not applicable
The table shows odds ratios (OR) with 95% confidence intervals (95% CI).